Prevention of herpes zoster

Infectious Disease Clinics of North America

Volumn 10, Issue 3, 1996, Pages 657-675

  Levin, M J ^a   Hayward, A R ^a  

^a Box C 227   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CHICKENPOX VACCINE;

AGING; CHICKENPOX; DORSAL ROOT; DRUG SAFETY; HERPES ZOSTER; HIGH RISK POPULATION; HUMAN; IMMUNE RESPONSE; IMMUNITY; IMMUNIZATION; INFECTION PREVENTION; PRIMARY INFECTION; REVIEW; VARICELLA ZOSTER VIRUS; AGED; DISEASE PREDISPOSITION; IMMUNOLOGY; MIDDLE AGED;

AGED; AGING; CHICKENPOX VACCINE; DISEASE SUSCEPTIBILITY; HERPES ZOSTER; HUMANS; MIDDLE AGED;

EID: 0030236614     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5520(05)70319-6     Document Type: Article

References (98)

1. A.A. Arvin C.M. Koropchak A.E. Wittek Immunologic evidence of reinfection with varicella-zoster virus J Infect Dis 148 1983 200 205
2. A.M. Arvin M. Sharp S. Smith Equivalent recognition of a varicella-zoster virus immediate early protein (IE62) and glycoprotein I by cytotoxic T lymphocytes of either CD4+ or CD8+ phenotype J Immunol 146 1991 257 264
3. Y. Asano N. Itakura Y. Hiroishi Viral replication and immunologic responses in children naturally infected with varicella-zoster virus and in varicella vaccine recipients J Infect Dis 152 1985 863 868
4. Y. Asano S. Suga T. Yoshikawa Experience and reason: Twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine Pediatrics 94 1994 524 526
5. Y. Asano M. Takahashi Clinical and serologic testing of a live varicella vaccine and two-year follow-up for immunity of the vaccinated children Pediatrics 60 1977 810 814
6. K. Baba H. Yabuuchi M. Takahashi P.L. Ogra Increased incidence of herpes zoster in normal children infected with varicella zoster virus during infancy. Community-based follow-up study J Pediatr 108 1986 372 377
7. H.H. Balfour Jr H.A. Rotbart S. Feldman Acyclovir treatment of varicella in otherwise healthy adolescents J Pediatr 120 1992 727 733
8. A.P. Barrett C.H. Katelaris J.G.L. Morris M. Schifter Zoster sine herpete of the trigeminal nerve Oral Surg Oral Med Oral Pathol 75 1993 173 175
9. G.J. Bennett Hypothesis on the pathogenesis of herpes zoster-associated pain Ann Neurol 35 1994 S38 S41
10. R.E. Bergen P.S. Diaz A.M. Arvin The immunogenicity of the Oka/Merck varicella vaccine in relation to infectious varicella-zoster virus and relative viral antigen content J Infect Dis 162 1990 1049 1054
11. R. Berger I. Amstutz M. Just D. Luescher Booster vaccination of healthy adults with VZV antibody but without a VZV-specific cell-mediated immune response Antiviral Res 1 1985 267 271
12. R. Berger G. Florent M. Just Decrease of the lymphoproliferative response to varicella-zoster virus antigen in the aged Infect Immun 32 1981 24 27
13. R. Berger D. Luescher M. Just Enhancement of varicella-zoster-specific immune responses in the elderly by boosting with varicella vaccine J Infect Dis 149 1984 647
14. R. Berger D. Leuscher M. Just Restoration of varicella-zoster virus cell-mediated immune response after varicella booster vaccination Postgrad Med J 61 1985 143 145
15. M.J. Bevan Antigen presentation to cytotoxic T lymphocytes in vivo J Exp Med 182 1995 639 641
16. P.A. Brunell J. Taylor-Wiedeman C.F. Geiser Risk of herpes zoster in children with leukemia: Varicella vaccine compared with history of chickenpox Pediatrics 77 1986 53 56
17. B. Bruusgaard The mutual relation between zoster and varicella Br J Dermatol 44 1932 1 18
18. B.L. Burke R.W. Steele O.W. Beard Immune responses to varicella-zoster in the aged Arch Intern Med 142 1982 291 293
19. E.A. Burns L.G. Lum G. L'Hommedieu J.S. Goodwin Specific humoral immunity in the elderly: In vivo and in vitro response to vaccination J Gerontol 48 1993 B231 B236
20. J. Chehimi N.M. Valiante A. D'Andrea Enhancing effect of natural killer cell stimulatory factor (NKSF/interleukin-12) on cell-mediated cytotoxicity against tumorderived and virus-infected cells Eur J Immunol 23 1993 1826 1830
21. Clarke P, Beer T, Cohrs R, Gilden DH: Configuration of latent varicella zoster virus DNA. J Virol Invest, in press
22. R.J. Cohrs M.B. Barbour R. Mahalingam Varicella-zoster virus (VZV) transcription during latency in human ganglia: Prevalence of VZV gene 21 transcripts in latently infected human ganglia J Virol 69 1995 2674 2678
23. R. Colebunders J.M. Mann H. Francis Herpes zoster in Africans: A clinical predictor of human immunodeficiency virus infection J Infect Dis 157 1988 314 318
24. K.D. Croen J.M. Ostrove L.J. Dragovic S.E. Straus Patterns of gene expression and sites of latency in human nerve ganglia are different for varicella-zoster and herpes simplex viruses Proc Natl Acad Sci USA 85 1988 9773 9777
25. S. Debrus C. Sadzot-Delvaux A.F. Nikkels Varicella-zoster virus gene 63 encodes an immediate-early protein that is abundantly expressed during latency J Virol 69 1995 3240 3245
26. J.M. de Moragas R.R. Kierland The outcome of patients with herpes zoster Arch Dermatol 75 1957 193 196
27. P.S. Diaz S. Smith E. Hunter A.M. Arvin Immunity to whole varicella-zoster virus antigen and glycoproteins I and p170: Relation to the immunizing regimen of live attenuated varicella vaccine J Infect Dis 158 1988 1245 1252
28. R. Dolin R.C. Reichman M.H. Mazur R.J. Whitley Herpes zoster-varicella infections in immunosuppressed patients Ann Intern Med 89 1978 375 388
29. L.M. Dunkle A.A. Arvin R.J. Whiteley A controlled trial of acyclovir for chickenpox in normal children N Engl J Med 325 1991 1539 1544
30. M. Duvic D. Grossman More on acyclovir for chickenpox [letter] N Engl J Med 331 1993 59
31. H.G. Easton Zoster sine herpete causing acute trigeminal neuralgia Lancet 2 1970 1065 1066
32. K.J. Elliott Taxonomy and mechanisms of neuropathic pain Semin Neurol 14 1994 195 205
33. S. Feldman W.T. Hughes H.Y. Kim Herpes zoster in children with cancer Am J Dis Child 126 1973 178 184
34. K. Fruh K. Ahn H. Djaballah A viral inhibitor of peptide transporters for antigen presentation Nature 375 1995 415 418
35. Y. Furuta T. Takasu S. Fukuda Detection of varicella-zoster in human geniculate ganglia by polymerase chain reaction J Infect Dis 166 1992 1157 1159
36. G.P. Garnett B.T. Grenfell The epidemiology of varicella-zoster virus infections: The influence of varicella on the prevalence of herpes zoster Epidemiol Infect 108 1992 513 528
37. L.D. Gelb D.E. Dohner A.A. Gershon Molecular epidemiology of live, attenuated varicella virus vaccine in children with leukemia and in normal adults J Infect Dis 155 1987 633 640
38. A.A. Gershon S.P. Steinberg Antibody responses to varicella-zoster virus and the role of antibody in host defense Am J Med Sci 282 1981 12 17
39. A.A. Gershon S.P. Steinberg P. LaRussa Immunization of healthy adults with live attenuated varicella vaccine J Infect Dis 158 1988 132 137
40. A.A. Gershon S.P. Steinberg NIAID Varicella Vaccine Collaborative Study Group Live attenuated varicella vaccine: Protection in healthy adults compared with leukemic children J Infect Dis 161 1990 661 666
41. A.A. Gershon P. LaRussa S. Steinberg The protective effect of immunologic boosting against zoster: An analysis in leukemic children who were vaccinated against chickenpox J Infect Dis 173 1996 450 453
42. D.H. Gilden Y. Rozeman R. Murray Detection of varicella-zoster virus nucleic acid in neurons of normal human thoracic ganglia Ann Neurol 22 1987 377 380
43. D.H. Gilden R.R. Wright S.A. Schneck Zoster sine herpete, a clinical variant Ann Neurol 35 1994 530 533
44. R.H. Gracely S.A. Lynch G.J. Bennett Painful neuropathy: Altered central processing maintained dynamically by peripheral input Pain 51 1992 175 194
45. A. Grossmann P.S. Rabinovitch T.J. Kavanagh Activation of murine T-cells via phospholipase-C gamma 1-associated protein tyrosine phosphorylation is reduced with aging J Gerontol 50 1995 B205 B212
46. I. Hardy A.A. Gershon S.P. Steinberg P. LaRussa The incidence of zoster after immunization with live attenuated varicella vaccine N Engl J Med 325 1991 1545 1550
47. Y. Hayakawa S. Torigoe K. Shiraki Biologic and biophysical markers of a live varicella vaccine strain (Oka): Identification of clinical isolates from vaccine recipients J Infect Dis 149 1984 956 963
48. A.R. Hayward K. Buda M.J. Levin Immune response to secondary immunization with live or inactivated VZV vaccine in elderly adults Viral Immunol 7 1994 31 35
49. A.R. Hayward R. Burger R. Scheper A.M. Arvin Major histocompatibility complex restriction of T-cell responses to varicella-zoster virus in guinea pigs J Virol 65 1991 1491 1495
50. A.R. Hayward M. Herberger Lymphocyte responses to varicella zoster virus in the elderly J Clin Immunol 7 1987 174 178
51. A. Hayward M. Levin W. Wolf Varicella-zoster virus-specific immunity after herpes zoster J Infect Dis 163 1991 873 875
52. A.R. Hayward G.O. Zerbe M.J. Levin Clinical applications of responder cell frequency estimates with four years of followup J Immunol Methods 170 1994 27 36
53. R.E. Hope-Simpson The nature of herpes zoster: A long-term study and a new hypothesis Proc R Soc Med 58 1965 9 21
54. R.E. Hope-Simpson Postherpetic neuralgia J R Coll Gen Pract 25 1975 571
55. R.W. Hyman J.R. Ecker R.B. Tenser Varicella-zoster virus RNA in human trigeminal ganglia Lancet 2 1983 814 816
56. T. Ihara K. Oitani S. Torigoe Cytotoxicity against varicella zoster virus infected targets in children with acute leukemia Acta Paediatr Jpn 36 1994 53 56
57. D.R. Jackola J.K. Ruger R.A. Miller Age-associated changes in human T-cell phenotype and function Aging (Milano) 6 1994 25 34
58. A.G.M. Langenberg R.L. Burke S.F. Adair A recombinant glycoprotein vaccine for herpes simplex type 2: Safety and efficacy Ann Intern Med 122 1995 889 898
59. M.J. Levin M. Murray H.A. Rotbart Immune response of elderly individuals to a live attenuated varicella vaccine J Infect Dis 166 1992 253 259
60. M.J. Levin M. Murray G.O. Zerbe Immune responses of elderly persons 4 years after receiving a live attenuated varicella vaccine J Infect Dis 170 1994 522 526
61. W. Liedtke B. Opalka Zimmerman E. Lignitz Age distribution of latent herpes simplex virus 1 and varicella-zoster virus genome in human nervous tissue J Neurol Sci 116 1993 6 11
62. P. Ljungman B. Lonnqvist G. Gahrton Clinical and subclinical reactivations of varicella-zoster virus in immunocompromised patients J Infect Dis 153 1986 840 847
63. J.P. Luby C. Ramirez-Ronda S. Rinner A longitudinal study of varicella-zoster virus infections in renal transplant recipients J Infect Dis 135 1977 659 663
64. E. Lydick R.S. Epstein D. Himmelberger C.J. White Area under the curve: A metric for patient subjective responses in episodic diseases Qual Life Res 4 1995 41 45
65. R. Mahalingam M.C. Wellish A.N. Dueland Localization of herpes simplex and varicella zoster virus DNA in human ganglia Ann Neurol 31 1992 441 448
66. R. Mahalingam M. Wellish W. Wolf Latent varicella-zoster viral DNA in human trigeminal and thoracic ganglia N Engl J Med 323 1990 627 631
67. E. Manickan R.J. Rouse Z. Yu Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes J Immunol 155 1995 259 265
68. E. Martz S.R. Gamble How do CTL control virus infections? Evidence for prelytic halt of herpes simplex Viral Immunol 5 1992 81 91
69. M.W. McKendrick J.I. McGill M.J. Wood Lack of effect of acyclovir on postherpetic neuralgia BMJ 298 1989 431
70. J.F. Meier R.P. Holman K.D. Croen Varicella-zoster virus transcription in human trigeminal ganglia Virology 193 1993 193 200
71. A.E. Miller Selective decline in cellular immune response to varicella-zoster in the elderly Neurology 30 1980 582 587
72. L. Molin Aspects of the natural history of herpes zoster Acta Derm Venereol 49 1969 569 583
73. S. Nader R. Bergen M. Sharp A.M. Arvin Age-related differences in cell-mediated immunity to varicella-zoster virus among children and adults immunized with live attenuated varicella vaccine J Infect Dis 171 1995 13 17
74. T. Nurmikko D. Bowsher Somatosensory findings in postherpetic neuralgia J Neurol Neurosurg Psychiatry 53 1990 135 141
75. T. Nurmikko C. Wells D. Bowsher Pain and allodynia in postherpetic neuralgia: Role of somatic and sympathetic nervous systems Acta Neurol Scand 84 1991 146 152
76. R. Paganelli E. Scala I. Quinti I.J. Ansotegui Humoral immunity in aging Aging (Milano) 6 1994 143 150
77. M.W. Ragozzino L.J. Melton III L.T. Kurland Population-based study of herpes zoster and its sequelae Medicine 61 1982 310 316
78. E.A. Rich M.A. Mincek K.B. Armitage Accessory function and properties of monocytes from healthy elderly humans for T lymphocyte responses to mitogen and antigen Gerontology 39 1993 93 108
79. R.S. Rogers III J.P. Tindall Geriatric herpes zoster J Am Geriatr Soc 19 1971 495 504
80. h2 cells J Clin Immunol 15 1995 121 129
81. A.S. Rosenberg J.M. Sechler J.A. Horvath Assessment of alloreactive T-cell subpopulations of aged mice in vivo. CD4+ but not CD8+ T-cell-mediated rejection response declines with advanced age Eur J Immunol 24 1994 1312 1316
82. H.A. Rotbart M.J. Levin A.R. Hayward Immune responses to varicella zoster virus infections in healthy children J Infect Dis 167 1993 195 199
83. P. Sansoni A. Cossarizza V. Brianti Lymphocyte subsets and natural killer cell activity in healthy old people and centenarians Blood 82 1993 2767 2773
84. K. Schmader L.K. George B.M. Burchett Racial differences in the occurrence of herpes zoster J Infect Dis 171 1995 701 704
85. F.E. Shaw H.A. Guess J.M. Roets The effect of anatomic injection site, age, and smoking on the immune response to hepatitis B vaccination Vaccine 7 1989 425 430
86. E. Somekh M.J. Levin Infection of human dorsal root neurons with wild type varicella virus and the Oka strain varicella vaccine J Med Virol 40 1993 241 243
87. S.J. Sperber B.V. Smith F.G. Hayden Serologic response and reactogenicity to booster immunization of healthy seropositive adults with live or inactivated varicella vaccine Antiviral Res 17 1992 213 222
88. Starr SE, Tinklepaugh C, Bocks E, et al: Immunization of healthy seropositive middle aged and elderly adults with varicella-zoster virus (VZV) vaccine [abstract No. 1237]. In Programs and Abstracts of the Twenty-Seventh Interscience Conference on Antimicrobial Agents and Chemotherapy, New York, 1987, p 313
89. S.E. Straus W. Reinhold H.A. Smith Endonuclease analysis of viral DNA from varicella and subsequent zoster infections in the same patient N Engl J Med 21 1984 1362 1364
90. K. Terada S. Kawano K. Yoshihiro T. Morita Varicella-zoster virus (VZV) reactivation is related to the low response of VZV-specific immunity after chickenpox in infancy J Infect Dis 169 1994 650 652
91. D.S. Ucker L.D. Hebshi J.F. Blomquist B.E. Torbett Title Physiological T-cell death: Susceptibility is modulated by activation, aging, and transformation, but the mechanism is constant Immunol Rev 142 1994 273 299
92. B. Watson S. Piercy D. Soppas The effect of decreasing amounts of live virus, while antigen content remains constant, on immunogenicity of Oka/Merck varicella vaccine J Infect Dis 168 1993 1356 1360
93. C.P.N. Watson Postherpetic neuralgia Neurol Clin 7 1989 231 248
94. T.H. Weller H.M. Witton The etiologic agents of varicella and herpes zoster: Serologic studies with the viruses as propagated in vitro Proc Soc Exp Biol Med 108 1958 869 888
95. C.J. White B.J. Kuter C.S. Hildebrand Varicella vaccine (Varivax) in healthy children and adolescents: Results from clinical trials, 1987 to 1989 Pediatrics 87 1991 604 610
96. A. Wilson M. Sharp C.M. Koropchak Subclinical varicella-zoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation J Infect Dis 165 1992 119 126
97. M.J. Wood Herpes zoster and pain Scand J Infect Dis 78 1991 53 61
98. S. Yasumoto Y. Moroi T. Koga Ultraviolet-B irradiation alters cytokine production by immune lymphocytes in herpes simplex virus-infected mice J Dermatol Sci 8 1994 218 223